Evidence map›Paper›PMID 40259859›Full record

ArticleClinical genetics2025

Biallelic FGF4 Variants Linked to Thoracic Dystrophy and Respiratory Insufficiency.

Laura M Watts, Esther Kinning, Donald R Latner, Marla Johnston, Jessica Patrick-Esteve, Gregory M Cooper, Stephen R F Twigg, Alistair T Pagnamenta, Jenny C Taylor

Abstract read
In one paragraph

Article in Clinical genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Laura M WattsOxford NIHR Biomedical Research Centre, Centre for Human Genetics, University of Oxford, Oxford, UK.
Esther KinningWest Midlands Regional Genetics Service, Birmingham Women's Hospital, Birmingham, UK.
Donald R LatnerHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.ORCID 0009-0005-0324-6916
Marla JohnstonChildren's Hospital New Orleans, New Orleans, Louisiana, USA.
Jessica Patrick-EsteveChildren's Hospital New Orleans, New Orleans, Louisiana, USA.
Gregory M CooperHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.ORCID 0000-0001-5509-9923
Stephen R F TwiggClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Alistair T PagnamentaOxford NIHR Biomedical Research Centre, Centre for Human Genetics, University of Oxford, Oxford, UK.
Jenny C TaylorOxford NIHR Biomedical Research Centre, Centre for Human Genetics, University of Oxford, Oxford, UK.

Funding

South-seq: DNA sequencing for newborn nurseries in the SouthU01HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI BARSH, GREGORY STEFAN, COOPER, GREGORY MICHAEL · 2017 to 2021
$11.9M
Long-read genome sequencing for the discovery of highly penetrant variation in rare diseasesR01HD112437 · NICHD · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI Gregory Michael Cooper, Jane Grimwood · 2024 to 2026
$1.8M
Medical Research Council MR/W01761X/1National Institute for Health and Care ResearchNCI NIH HHS U01HG007301NHGRI NIH HHSNHGRI NIH HHS U01 HG007301NICHD NIH HHS R01 HD112437NIHR Oxford Biomedical Research CentreNIMHD NIH HHSWellcome TrustWellcome Trust 203141/Z/16/Z
6 · The paper itself

Abstract

The thoracic dystrophies are inherited skeletal conditions where abnormal embryonic development of the thoracic skeleton results in a narrow chest, pulmonary hypoplasia, and respiratory insufficiency, which can be severe or lethal. The majority of thoracic dystrophies are due to biallelic alterations in genes needed for normal ciliary function. However, despite the identification of over 20 genes as causal for the thoracic dystrophy phenotype, around 20% of patients remain without a molecular diagnosis. We present two unrelated families with a clinical diagnosis of thoracic dystrophy with associated respiratory insufficiency without a molecular diagnosis on previous genetic testing. Both harbor rare biallelic and predicted deleterious missense substitutions in FGF4, a gene known to be essential for formation of the thoracic skeleton in mice. We demonstrate that the phenotype is restricted to short ribs, abnormally narrow chest, and respiratory insufficiency, without other diagnostic clinical or radiological signs. We suggest that biallelic alterations in FGF4 are a newly identified disease association of thoracic dystrophy.

Indexed as

Fibroblast Growth Factor 4Genetic Predisposition to DiseaseRespiratory InsufficiencyAdultAllelesChildFemaleGenetic Association StudiesHumansMaleMutation, MissensePedigreePhenotypeFibroblast Growth Factor 4fibroblast growth factor 4pulmonary hypoplasiaskeletal dysplasiathoracic dystrophy

Identifiers

PMID40259859
PMCPMC12353327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.